CDK12-HNF4A轴调控AKI肾小管损伤及机制研究，国家自然科学基金专项项目，2023.01- 2025.12，在研，主持，排1

巨噬细胞源性外泌体miR-155调控肾小管上皮细胞衰老的机制研究，国家自然科学基金面上项目，2021.01- 2024.12，在研，主持，排1

罕见肾脏病多维度筛诊体系建设与推广，江苏省科技计划专项项目，2023.07-2026.06，在研，主持，排1

东南大学“至善青年项目”，东南大学，2022年，在研，主持，排1

托伐普坦在肾病患者容量管理中的精准应用，中国心血管健康联盟诺创高血压科研创新基金，2022-01-2024-01，在研，主持，排1

RVG修饰外泌体运载miR-26a对尿毒症心肌损害的治疗作用研究，江苏省自然科学基金面上项目，2018-07-01-2020-06-3010，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴对miR-26a表达调控的研究，国家自然科学基金青年项目，2017-08-06-2020-12-31，结题，主持，排1

成纤维细胞生长因子21与血液透析患者血管钙化的相关性研究和机制初探，中华医学会临床医学科研专项资金项目，2020-03-31-2022-03-31，结题，主持，排1

血液透析患者膈肌功能障碍的临床研究，江苏省“六大人才”高峰项目C类一项，2018-06-01-2020-12-31，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴.miR-26a表达调控的研究，东南大学高水平论文扶持项目，2018-01-01-2019-12-31，结题，主持，排1

CDK12-HNF4A轴调控AKI肾小管损伤及机制研究，国家自然科学基金专项项目，2023.01- 2025.12，在研，主持，排1

巨噬细胞源性外泌体miR-155调控肾小管上皮细胞衰老的机制研究，国家自然科学基金面上项目，2021.01- 2024.12，在研，主持，排1

罕见肾脏病多维度筛诊体系建设与推广，江苏省科技计划专项项目，2023.07-2026.06，在研，主持，排1

东南大学“至善青年项目”，东南大学，2022年，在研，主持，排1

托伐普坦在肾病患者容量管理中的精准应用，中国心血管健康联盟诺创高血压科研创新基金，2022-01-2024-01，在研，主持，排1

RVG修饰外泌体运载miR-26a对尿毒症心肌损害的治疗作用研究，江苏省自然科学基金面上项目，2018-07-01-2020-06-3010，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴对miR-26a表达调控的研究，国家自然科学基金青年项目，2017-08-06-2020-12-31，结题，主持，排1

成纤维细胞生长因子21与血液透析患者血管钙化的相关性研究和机制初探，中华医学会临床医学科研专项资金项目，2020-03-31-2022-03-31，结题，主持，排1

血液透析患者膈肌功能障碍的临床研究，江苏省“六大人才”高峰项目C类一项，2018-06-01-2020-12-31，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴.miR-26a表达调控的研究，东南大学高水平论文扶持项目，2018-01-01-2019-12-31，结题，主持，排1

1.Wang B, Wang Y, Wen Y, Zhang YL, Ni WJ, TangTT, et al. Tubular-specific CDK12 knockout causes a defect in urineconcentration due to premature cleavage of the slc12a1 gene. Mol Ther.2022;30:3300-12.

2.Wang B, Qian JY, Tang TT, Lin LL, Yu N, GuoHL, et al. VDR/Atg3 axis regulates slit diaphragm to tight junction transitionvia p62-mediated autophagy pathway in diabetic nephropathy. Diabetes.2021;70:2639-51.

3.Wang B, Wang ZM, Ji JL, Gan W, Zhang A, ShiHJ, et al. Macrophage-Derived Exosomal Mir-155 Regulating CardiomyocytePyroptosis and Hypertrophy in Uremic Cardiomyopathy. JACC Basic Transl Sci.2020;5:148-66.

4.Tang TT#, Wang B#, Wu M, Li ZL, Feng Y, CaoJY, et al. Extracellular vesicle-encapsulated IL-10 as novel nanotherapeuticsagainst ischemic AKI. Sci Adv. 2020;6:z748.

5.Wang B, Zhang C, Zhang A, Cai H, Price SR,Wang XH. MicroRNA-23a and MicroRNA-27a Mimic Exercise by AmelioratingCKD-Induced Muscle Atrophy. J Am Soc Nephrol. 2017;28:2631-40.

6.Tang TT#, Wang B#, Li ZL, Wen Y, Feng ST, WuM, et al. Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform forRNAi to Treat AKI. J Am Soc Nephrol. 2021;32:2467-83.

7.Yin Q, Zhao YJ, Ni WJ, Tang TT, Wang Y, CaoJY, et al, Liu BC*, Wang B*. MiR-155 deficiency protects renal tubularepithelial cells from telomeric and genomic DNA damage in cisplatin-inducedacute kidney injury. Theranostics. 2022;12:4753-66.

8.Ni WJ#, Li ZL#, Wen XL, Ji JJ, Liu H, Yin Q,et al, Liu BC*, Wang B*. HIF-1α and adaptor protein LIM and senescent cellantigen-like domains protein 1 axis promotes tubulointerstitial fibrosis byinteracting with vimentin in angiotensin II-induced hypertension. Br JPharmacol. 2024 May 3.（Onlineahead of print）.

9.Zhang YL, Tang TT, Ni WJ, Li ZT, Jiang LYZ,Wang Y, et al, Liu BC*, Wang B*. Tubule-specific cyclin-dependent kinase 12 knockdown potentiates kidneyinjury through transcriptional elongation defects. Int J Biol Sci.2024;12;20:1669-87.

10.Ni WJ, Zhao YJ, Shen jx, Yin Q, Wang Y, LiZL, et al, Wang B*, Liu BC*. Therapeutic role of miR-26a on cardiaorenal injuryin mice model of angiotensin-II induced chronic kidney disease throughinhibition of LIMS1/ILK pathway. Chin Med J (Engl). 2024 Mar 6.（Onlineahead of print）.

11.Sheng MJ, Cao JY, Hou SM, Li M, Wang Y, FangQ, et al, Wang B*.  Computedtomography-determined skeletal muscle density predicts 3-year mortality ininitial-dialysis patients in China. J Cachexia Sarcopenia Muscle.2023;14:2569-78. 

12.Yin D, Cao JY, Yang Y, Li ZT,  Liu H, Tang TT, et al, Liu BC*, Wang B*. Quercetin alleviatestubulointerstitial inflammation by inhibiting exosomes-mediated crosstalkbetween tubular epithelial cells and macrophages. Inflamm Res.2023;72:1051-67. 

13.Ji JJ, Shi HM, Li ZL, Jin R, Qu GT, Zheng H,et al, Wang B*, Zhang AQ*. Satellite cell-derived exosome-mediated delivery ofmicroRNA-23a/27a/26a cluster ameliorates the renal tubulointerstitial fibrosisin mouse diabetic nephropathy. Acta Pharmacol Sin. 202;44:2455-68. 

14.Zheng J, Yin Q, Wang SY, Wang YY, Xiao JJ,Tang TT, et al, Liu BC*, Wang B*. Ultrasound-assessed diaphragm dysfunctionpredicts clinical outcomes in hemodialysis patients. Sci Rep. 2022;12:16550.

15.Gao YM, Feng ST, Wen Y, Tang TT, Wang B*,Liu BC*. Cardiorenal protection of SGLT2 inhibitors-Perspectives from metabolicreprogramming. EBioMedicine. 2022;83:104215.

16.Wang B, Li ZL, Zhang YL, Wen Y, Gao YM, LiuBC. Hypoxia and chronic kidney disease. EBioMedicine. 2022;77:103942.

17.Ni HF, Yang Y, Li CQ, Zhou TZ, Liu BC, WangB*. Myeloid bodies caused by COQ2 mutation: a case of concurrent COQ2nephropathy and IgA nephropathy. Clin Kidney J. 2021;14:1697-700.

18.Wang FM, Yang Y, Zhang XL, Wang YL, Tu Y,Liu BC, Wang B*. Combination of a Novel Genetic Variant in CFB Gene and aPathogenic Variant in COL4A5 Gene in a Sibling Renal Disease: A Case Report.Frontiers in Genetics. 2021;12:690952.

19. Li ZL, Wang B*, Wen Y, Wu QL, Lv LL, LiuBC*. Disturbance of Hypoxia Response and Its Implications in Kidney Diseases.Antioxid Redox Signal. 2022 Nov;37:936-55.

20.Li ZL, Ji JL, Wen Y, Cao JY, Kharbuja N,Ni WJ, et al, Liu BC*, Wang B*. HIF-1alpha is transcriptionally regulated byNF-kappaB in acute kidney injury. Am J Physiol Renal Physiol. 2021;321:F225-35.

21.Li ZL, Wang B*, Lv LL, Tang TT, Wen Y, CaoJY, et al, Liu BC*. FIH-1-modulated HIF-1alpha C-TAD promotes acute kidneyinjury to chronic kidney disease progression via regulating KLF5 signaling.Acta Pharmacol Sin. 2021;42:2106-19. doi: 10.1038/s41401-021-00617-4.

22. Wang H#, Wang B#, Zhang A, Hassounah F,Seow Y, Wood M, et al. Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophyand Kidney Fibrosis in Mice. Mol Ther. 2019;27:571-83.

23. Wang B, Zhang A, Wang H, Klein JD, Tan L,Wang ZM, et al. miR-26a Limits Muscle Wasting and Cardiac Fibrosis throughExosome-Mediated microRNA Transfer in Chronic Kidney Disease. Theranostics.2019;9:1864-77.

24. Cao JY#, Wang B#, Tang TT#, Wen Y, Li ZL,Feng ST, et al. Exosomal miR-125b-5p deriving from mesenchymal stem cellspromotes tubular repair by suppression of p53 in ischemic acute kidney injury.Theranostics. 2021;11:5248-66.

25. Wang B, Wang J, He W, Zhao Y, Zhang A, LiuY, et al. Exogenous miR-29a Attenuates Muscle Atrophy and Kidney Fibrosis inUnilateral Ureteral Obstruction Mice. Hum Gene Ther. 2020;31:367-75.

26. Wang B, Yin Q, Wang YY, Tu Y, Han Y, Gao M,et al. Diaphragmatic dysfunction associates with dyspnoea, fatigue, and hiccupin haemodialysis patients: a cross-sectional study. Sci Rep. 2019;9:19382.

27. Qian FY, Li ZL, Guo YD, Gao HC, Gu LH, LeK, et al, Wang B*，ZhangZ J*. Hypoxia-inducible factor-prolyl hydroxylase inhibitor amelioratesmyopathy in a mouse model of chronic kidney disease. Am J Physiol RenalPhysiol. 2019;317:F1265-73.

28. Tu Y, Sheng MJ, Wang YL, Wang ZJ, Zhang XL,Liu BC, Wang B*. A Woman With "Polycystic Kidney Disease". Kidney IntRep. 2020;5:1367-70.

29. Jiang L, Yin Q, Yang M, Li M, Pan M, Han Y,et al, Wang B*. Fibroblast Growth Factor 21 Predicts and Promotes VascularCalcification in Haemodialysis Patients. Kidney Dis (Basel). 2021;7:227-40.